Skip to main content

Phenomenex to Distribute Beckman’s Protein/Peptide-Separation Tool

NEW YORK (GenomeWeb News) — Phenomenex today said it will distribute Beckman Coulter’s protein-partitioning and depletion product in North America and in Europe.
 
Under the agreement, Torrance, Calif.-based Phenomenex will market and sell Beckman’s ProteomeLab IgY-12. The IgY is based on avian-generated antibodies and “delivers an enriched proteome that includes medium and low-abundance proteins that are of interest to biomarker research,” Phenomenex said.  
 
Michael McGinley, Phenomenex’s biochromatography product manager, said the IgY will “fit well” with the company’s proteomics offerings for protein and peptide separation.
 
Financial terms of the agreement were not released.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.